Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Unno

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
British Journal of Cancer|April 17, 2015
Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancerS Ohkawa, T Okusaka, H Isayama, et al.
Gastroenterology|May 29, 2001
LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancersT Abe, M Unno, T Onogawa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 15, 2025
The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter studyE Rangelova, T F Stoop, T M E van Ramshorst, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
British Journal of Cancer|April 17, 2015
Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancerS Ohkawa, T Okusaka, H Isayama, et al.
Gastroenterology|May 29, 2001
LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancersT Abe, M Unno, T Onogawa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 15, 2025
The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter studyE Rangelova, T F Stoop, T M E van Ramshorst, et al.
Pageof 11